• ARCA Cy5 EGFP mRNA (5-moUTP): Optimizing mRNA Delivery Assay

  2026-07-29

  ARCA Cy5 EGFP mRNA (5-moUTP) enables direct, high-sensitivity analysis of mRNA delivery, localization, and translation in mammalian cells. With 5-methoxyuridine modification and robust Cy5/EGFP dual fluorescence, this APExBIO reagent streamlines protocol design and troubleshooting for next-generation mRNA delivery system research.

• Cy5-UTP in RNA Labeling: Protocols, Troubleshooting, and Adv

  2026-07-29

  Cy5-UTP (Cyanine 5-UTP) revolutionizes RNA probe synthesis by enabling direct, high-sensitivity detection in complex biological assays. This guide delivers stepwise workflows, optimization tips, and applied insights to maximize success in FISH, dual-color arrays, and mechanistic neurobiology studies.

• PLGA Nano-Adjuvant Boosts Mucosal Immunity in H9N2 Vaccinati

  2026-07-28

  This study introduces a PLGA-based nano-adjuvant that markedly enhances both mucosal and systemic immune responses to H9N2 avian influenza vaccination in chicks. By targeting the intestine and sustaining antigen release, the adjuvant overcomes limitations of current vaccines, offering a promising advance for poultry immunology.

• Sulfo-Cy5 Carboxylic Acid: Precision Fluorescent Dye for Lif

  2026-07-28

  Sulfo-Cy5 carboxylic acid stands out as a hydrophilic fluorescent dye for life sciences, minimizing fluorescence quenching and enabling high-sensitivity protein and peptide labeling in aqueous workflows. Its robust optical properties and water solubility empower advanced imaging and quantitative analysis, especially in mucosal immunity and nanoparticle vaccine studies.

• ECL Western Blotting Substrate: Technical Protocol and Usage

  2026-07-27

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of horseradish peroxidase (HRP) in protein detection by chemiluminescence. This reagent is suitable for Western blot assays in molecular biology, cancer biology, and signal transduction pathway research, but should not be used for fluorescent or radioisotopic protocols.

• T-5224: C-Fos/AP-1 Inhibitor for Translational Inflammation

  2026-07-27

  T-5224, a selective C-Fos/AP-1 inhibitor, empowers researchers to dissect neuroinflammatory and arthritic pathways with precision. Its proven efficacy in modulating MMPs and cytokines, robust in vivo bioavailability, and targeted gene regulation make it indispensable for advanced inflammation and arthritis research.

• Bestatin hydrochloride (A8621): Reliable Inhibitor for Tumor

  2026-07-26

  This article addresses common laboratory challenges in cell-based assays by exploring how Bestatin hydrochloride (SKU A8621) enables reproducible, sensitive results in angiogenesis and tumor biology workflows. Citing peer-reviewed data, validated protocols, and vendor selection criteria, we demonstrate why Bestatin hydrochloride from APExBIO is a dependable tool for biomedical researchers seeking robust aminopeptidase inhibition.

• ARCA Cy5 EGFP mRNA (5-moUTP): Advancing mRNA Localization As

  2026-07-25

  ARCA Cy5 EGFP mRNA (5-moUTP) from APExBIO sets the standard for quantifiable, immune-evasive mRNA delivery and localization studies in mammalian cells. Its robust, fluorescently labeled design streamlines transfection analysis, enabling high-sensitivity tracking across advanced mRNA delivery systems.

• Early Pheromone Perception Accelerates Neurodegeneration in

  2026-07-24

  Peng et al. (2023) reveal that exposure to specific pheromones during early development in C. elegans leads to lasting neurodevelopmental changes that accelerate neurodegeneration in adulthood. Their work uncovers a mechanistic pathway linking environmental sensing to neuronal aging, providing foundational insights for modeling neurodegenerative disease risk.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Signal Amplificatio

  2026-07-24

  Unlock advanced sensitivity in immunofluorescence and immunohistochemistry with the Cy5 Goat Anti-Rabbit IgG (H+L) Antibody. This APExBIO reagent empowers researchers to dissect antiviral signaling with robust fluorescence amplification, streamlined troubleshooting, and reproducible workflow enhancements.

• Macrophage EV miR-660 Drives Breast Cancer via KLHL21–NF-κB

  2026-07-23

  This study elucidates how tumor-associated macrophage (TAM)-derived extracellular vesicles (EVs) containing microRNA-660 (miR-660) foster breast cancer progression by downregulating KLHL21 and activating the IKKβ/NF-κB p65 pathway. The findings highlight a novel tumor-promoting mechanism within the tumor microenvironment, suggesting new molecular targets for translational breast cancer research.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Reporter Maste

  2026-07-23

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) from APExBIO empowers researchers with simultaneous fluorescence and bioluminescence tracking, enabling real-time insights into mRNA delivery, expression, and immune evasion. Its advanced Cap1 capping and 5-moUTP modifications streamline translational workflows and elevate signal reliability in both in vitro and in vivo experimental models.

• 7ACC2: Defining Precision in MCT1 Inhibition for Metabolic O

  2026-07-22

  Explore how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, advances cancer metabolism research by enabling precision control of lactate uptake inhibition. This article uniquely dissects the strategic selection and application of 7ACC2, with a focus on protocol optimization and immunometabolic assay design.

• SP600125: Strategic JNK Inhibition for Translational Impact

  2026-07-22

  This thought-leadership article provides translational researchers with a mechanistic and strategic guide to leveraging SP600125—a selective JNK inhibitor—in advanced models of apoptosis, inflammation, and cytokine modulation. Integrating insights from recent literature, including Nrf2 pathway regulation, and benchmarking against related assets, the piece delivers actionable experimental guidance, competitive differentiation, and a forward-looking perspective on the evolving role of JNK inhibition in disease modeling and therapeutic innovation.

• Patient-Derived Organoids Illuminate Adenomyoepithelioma Bio

  2026-07-21

  This study reports the first successful derivation and characterization of organoids from adenomyoepithelioma (AME) of the breast, establishing a clinically relevant 3D model to investigate tumor biology and drug sensitivity. The organoid platform opens new avenues for understanding AME pathogenesis and for preclinical testing of therapeutic agents.

16431 records 1/1096 page Next 12345 下5页 Last page